Abstract
Comment on: Heerspink HJL, Parving HH, Andress DL, et al. Atrasentan and renal events in patients with type 2 diabetes and chronic kidney disease (SONAR): a double-blind, randomised, placebo-controlled trial.
Cite
CITATION STYLE
APA
Cahn, A., Cernea, S., & Raz, I. (2019). The SONAR study—is there a future for endothelin receptor antagonists in diabetic kidney disease? Annals of Translational Medicine, 7(S8), S330–S330. https://doi.org/10.21037/atm.2019.09.117
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free